FDA grants Fast Track Designation to Complement Therapeutics’ CTx001 for geographic atrophy | Optometry Times - Clinical News

Published on January 20, 2026
The Investigational New Drug (IND) application from Complement Therapeutics for CTx001 was previously approved by the FDA in October 2025.